← FDA DRUG APPROVALS

FDA ANDA · ANDA075037

ISOSORBIDE MONONITRATE

Sponsor: GENUS

APPLICATION
ANDA075037
TYPE
ANDA
ORIGINAL APPROVAL
1998-10-30
LATEST ACTION
2001-11-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ISOSORBIDE MONONITRATEPrescription
ISOSORBIDE MONONITRATE 20MG · TABLET · ORAL
ISOSORBIDE MONONITRATEPrescription
ISOSORBIDE MONONITRATE 10MG · TABLET · ORAL

Approval history

2001-11-02Manufacturing (CMC) · Supplement 3AP
2000-04-17Labeling · Supplement 2AP
1999-11-24Labeling · Supplement 1AP
1998-10-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →